Junshi wins European approval for cheaper checkpoint blocker – The Pharma Letter

Junshi wins European approval for cheaper checkpoint blocker  The Pharma LetterJunshi’s toripalimab secures EC approval for NPC and ESCC treatment  World Pharmaceutical FrontiersToripalimab Gains EC Approval for Cancer Treatment  TipRanks
Read More…

Source: https://www.thepharmaletter.com/biotechnology/junshi-wins-european-approval-for-key-cancer-drug-toripalimab